Document is current

Any future updates will be listed below

The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties

Crossref DOI link: https://doi.org/10.1007/s13318-014-0242-5

Published Online: 2014-12-05

Published Print: 2016-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark